De Burlo Group Inc Biogen Inc. Transaction History
De Burlo Group Inc
- $741 Million
- Q4 2024
Shares
3 transactions
Others Institutions Holding BIIB
# of Institutions
1,006Shares Held
126MCall Options Held
1.77MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.33 Billion0.05% of portfolio
-
Primecap Management CO Pasadena, CA16MShares$2.23 Billion1.94% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.02 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$1.03 Billion0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA3.7MShares$514 Million0.04% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...